SelectScience InterviewsLife Sciences

Automating Assay Development for Early Stage Drug Discovery

3 Nov 2017
Automating Assay Development for Early Stage Drug Discovery

Likarda LLC, a contract research organization, works with clients at the early stages of drug development and discovery. Dr Lisa Stehno-Bittel, President & Co-founder of Likarda, discusses how the company develops 3D cell clusters, which are indicative of native tissues in the body, for use in cell-based assays. Hear from research scientist Stephen Harrington PhD, Likarda’s Director of Production, how the team has utilized automation to increase throughput and reproducibility, most recently employing the Integra Assist to bridge the gap between manual bench work and complete automation.

About the company

SelectScience logo

SelectScience

Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.

Other videos from SelectScience

Links

Automating Assay Development for Early Stage Drug Discovery